Individualized Home-based Exercise Program for Patient With Systemic Sclerosis.
ESSE2016
Effects of an Individualized, Home-based Exercise Program for the Patient With Systemic Sclerosis, on Exercise Capacity, Hand Mobility and Quality of Life: a Randomized, Controlled Study.
1 other identifier
interventional
33
1 country
1
Brief Summary
Systemic sclerosis (SSc) is an uncommon chronic rheumatic disease with an unknown cause and unpredictable course. The inability, in addition to easy fatigability, starts a vicious circle that leads to a fast deterioration of physical conditions that cause a reduction of aerobic exercise capacity and, consequently, of health-related quality of life (HRQoL). Aerobic exercise has already been shown to be safe and effective in improving exercise capacity and HRQoL of patients with chronic cardiovascular and pulmonary diseases. However, few studies have evaluated the role of specific exercise programs on the muscular impairment in SSc. Nevertheless, the results obtained in preliminary reports are promising, and, for these reasons, the management of muscular impairment in SSc could include an appropriate rehabilitation program besides pharmaceutical and surgical treatments. The primary aim of this study will be to evaluate the effect of an individualized exercise program performed at home on aerobic capacity evaluated by 6 minutes walking test. Secondary aims will be to evaluate: 1- VO2max, measured by cardiopulmonary test; 2- the effect of the same program on the muscular strength of upper and lower limbs; 3- the efficacy of a self-administered stretching program for finger joint motion. Secondary aims will be also 1-to ascertain whether a comprehensive exercise program may affect, besides physical function, HRQoL; 2- and to evaluate the adherence during two periods of three months, one whit and one without supervision and reinforcement by a phone call. All the patients with a diagnosis of SSc, according to the criteria of American College of Rheumatology (ACR), who attended the Rheumatologic outpatient clinic of our institution will be evaluated in order to participate in the rehabilitation program. The pneumological examination and two days of screening and testing will take place at the outpatient's clinic of Respiratory Medicine and Sport of our institution.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedFirst Submitted
Initial submission to the registry
July 26, 2018
CompletedFirst Posted
Study publicly available on registry
August 3, 2018
CompletedAugust 3, 2018
August 1, 2018
1.1 years
July 26, 2018
August 2, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Six minute walking test
Evaluate aerobic capacity
Up to six months
Secondary Outcomes (9)
Maximum oxygen consumption (VO2max)
Up to six months
Handgrip strength
Up to six months
Muscular strength of upper limbs
Up to six months
One repetition maximum (1-RM) of biceps strength
Up to six months
Muscular strength of lower limbs
Up to six months
- +4 more secondary outcomes
Study Arms (2)
Home-care rehabilitation group (HCRG)
EXPERIMENTALThe home-based exercise program consists of aerobic exercise on a stationary bike, muscular endurance training of the upper limb and stretching exercises for finger joint motion. The exercise on the stationary bike and muscular endurance training will be performed on alternate days, three times a week. For finger stretching the patients will be directed to perform it every day, both in the morning and in the evening. During the rehabilitation period, the patients will report each day on a diary for each type of exercise. They received a phone call monthly, only for the first 3 months, to encourage them about the adherence and investigate any problems with the exercise program.
Control group
NO INTERVENTIONControl group was encouraged to perform the generic aerobic physical activity at the baseline. Also, they received a monthly phone call, only for the first 3 months, to encourage them about the importance of doing aerobic exercise.
Interventions
The exercise program consists of aerobic exercise on a stationary bike, muscular endurance training of the upper limb and stretching exercises for finger joint motion. The exercise on the stationary bike and muscular endurance training will be performed on alternate days, three times a week.
Eligibility Criteria
You may qualify if:
- diagnosis of SSc according to the criteria of ACR
- no hospitalizations in the previous 3 months
- no change in anti-rheumatic treatment in the previous 3 months
- signed informed consent
You may not qualify if:
- heart failure staging in classes III or IV of New York Heart Association (NYHA)
- pulmonary hypertension, defined by echocardiogram as a right ventricular systolic pressure ≥ 45mmHg
- vital capacity (VC) ≤ 50% or diffusion lung capacity of carbon monoxide (DLCO) ≤ 30% of predicted values.
- renal failure defined as a calculated glomerular filtration rate (GFR) \< 30ml/min, in agreement with the staging of International Federation of National Kidney Foundations
- inability to perform the rehabilitation program due to skeletal-muscle impairments or other illnesses
- pregnancy or planned pregnancy in the next 6 months
- psychiatric disorders that prevent collaboration and adherence at the rehabilitation the program, including drug abuse
- involvement in ongoing aerobic or anaerobic exercise programs
- Drop out criteria:
- the demonstration of ischemic heart disease after cardiopulmonary exercise testing performed at baseline
- need to change the dosage or interruption of prostanoids used in the treatment of SSc during the 6 months of the treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azienda Ospedaliera, SSO respiratory pathophysiology Unit, Verona
Verona, Italy/Verona, 37134, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marcello Ferrari, Professor
Universita di Verona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 26, 2018
First Posted
August 3, 2018
Study Start
February 1, 2017
Primary Completion
March 1, 2018
Study Completion
March 1, 2018
Last Updated
August 3, 2018
Record last verified: 2018-08